Latest database descriptions

In terms of public health (surveillance, evaluation):
- Fill in the absence of French data on the incidence, mortality, handicap and recurrence rates of stroke and TIA
- Evaluate this data in order to assess the impact of the measures of prevention, curative treatments and medical practices

In terms of research:
- Obtain objective epidemiological data on stroke and TIA in a well-defined population in order to evaluate the frequency, the severity and the cost
- Evaluate new etiologies leading to screening and prevention campaigns for stroke and TIA
- Evaluate the care practices in the Hospital, Clinics and at home in Dijon and the intervention campaigns
- Provoke experimental work on the physiopathology of stroke and TIA that should result in new therapies
- Provoke the setting up of a network of the various stakeholders intervening in caring for stroke and TIA in the town of Dijon but also in the Burgundy region

The objective of this study was to better understand the use of anti-inflammatory drugs, cyclo-oxygenase 2 (COX-2) or coxib (Vioxx®, Celebrex®) and traditional anti-inflammatory drugs (tNSAIDs, e.g. Aspirin, Ibuprofen) in France and to describe and assess the risks of adverse events possibly related to treatment.

Main Objective: To identify, through the creation of a clinico-biological, prospective, multicentric French database, the clinical, biological and tumour factors linked to anti-tumour therapy resistance in patients treated for stage I to IV oesophageal or stomach cancer. Secondary Objectives: - To assess the impact of different current therapeutic strategies for recurrence, survival and quality of life. - To identify predictive factors for patient treatment resistance in order to identify the most efficient and least toxic therapeutic combination. - To describe individual, social and behavioural characteristics of patients included in the study. - To identify individual and collective determinants that influence possible access to care and initiation of treatment. - To identify new prognostic and predictive relapse factors.

The French National Occupational Diseases Surveillance and Prevention Network (RNV3P) groups together the 32 Occupational Disease Consultation Centres (CCPPs) in mainland France and a sample of 10 occupational health services (SSTs) associated with the network. This network aims to collect data from each consultation in a permanent national database on occupational diseases (patient’s demographic data, diseases, exposures, business sector and profession). The RNV3P has two interrelated components: "RNV3P-CCPP" and "RNV3P-SST". The former is a surveillance system for CCPP patient consultations while the latter is a survelliance system for the working population. One of the original aims of RNV3P is to record CCPP expertise on the causal nature of relations between occupational exposure and diseases observed in patients. It is up to the network's university-hospital experts to investigate the diseases and attribute them, if necessary, to an occupational origin (this causality is also registered in the database). The RNV3P is not a health surveillance system that gives a representative picture of actual disease frequency in a given field. Its main objectives are to identify and describe at-risk occupational situations in France, and to research new etiologies and emerging occupational health risks. As a network operator, ANSES is responsible for coordinating all activities associated with the network and to participate in related scientific work in partnership with the State Health Insurance Fund for Salaried Workers (CNAM-TS), the Central Health and Social Security Insurance Fund for Agricultural Employees (CCMSA), the French Institute for Public Health Surveillance (InVS), and the French Occupational Medicine Society (SFMT).